<SEC-DOCUMENT>0001104659-20-023475-index.html : 20200220
<SEC-HEADER>0001104659-20-023475.hdr.sgml : 20200220
<ACCEPTANCE-DATETIME>20200220172443
ACCESSION NUMBER:		0001104659-20-023475
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20200213
ITEM INFORMATION:		Termination of a Material Definitive Agreement
ITEM INFORMATION:		Completion of Acquisition or Disposition of Assets
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20200220
DATE AS OF CHANGE:		20200220

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Assertio Therapeutics, Inc
		CENTRAL INDEX KEY:			0001005201
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				943229046
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-13111
		FILM NUMBER:		20636441

	BUSINESS ADDRESS:	
		STREET 1:		100 SOUTH SAUNDERS RD
		STREET 2:		SUITE 300
		CITY:			LAKE FOREST
		STATE:			IL
		ZIP:			60045
		BUSINESS PHONE:		(224) 419-7106

	MAIL ADDRESS:	
		STREET 1:		100 SOUTH SAUNDERS RD
		STREET 2:		SUITE 300
		CITY:			LAKE FOREST
		STATE:			IL
		ZIP:			60045

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	DEPOMED INC
		DATE OF NAME CHANGE:	19970408
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>tm209525d1_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
Document 1 - file: tm209525d1_8k.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-2.1
<SEQUENCE>2
<FILENAME>tm209525d1_ex2-1.htm
<DESCRIPTION>EXHIBIT 2.1
<TEXT>
Document 2 - file: tm209525d1_ex2-1.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>3
<FILENAME>tm209525d1_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
Document 3 - file: tm209525d1_ex99-1.htm

</DOCUMENT>
</SEC-DOCUMENT>